Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted molecular imaging agents for cellular-scale bimodal imaging.

H Charles Manning1, Timothy Goebel, Reid C Thompson

  • 1Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, USA. darryl.bornhop@vanderbilt.edu

Bioconjugate Chemistry
|November 18, 2004
PubMed
Summary

This study introduces a new molecular imaging agent for detecting peripheral benzodiazepine receptor (PBR) overexpression in brain cancer cells. The agent enables multimodal imaging, aiding early disease detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycoprotein mucin 13 expression as a theranostic target in colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Immune Subtypes and Survival in Patients with Primary Glioma.

medRxiv : the preprint server for health sciences·2026
Same author

Targeting genomic instability in cancer.

Cell·2026
Same author

Contemporary opportunities and potential of Auger electron-emitting theranostics.

Theranostics·2026
Same author

Understanding the Compatibility of Fluoride-Based Radiopharmaceutical Reaction Solutions and PDMS.

ACS applied materials & interfaces·2025
Same author

Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors.

NMR in biomedicine·2025

Area of Science:

  • Biomedical imaging
  • Molecular biology
  • Radiochemistry

Background:

  • Molecular imaging aids in understanding disease mechanisms and early detection.
  • Peripheral benzodiazepine receptor (PBR) is overexpressed in various diseases like glioblastoma, breast cancer, and Alzheimer's.
  • PBR is a potential target for molecular imaging agents.

Purpose of the Study:

  • To evaluate a novel lanthanide chelate molecular imaging agent targeting PBR.
  • To assess cellular uptake and multimodal imaging (MRI and fluorescence) of PBR-overexpressing cells.
  • To investigate the potential of PBR as a target for brain cancer imaging.

Main Methods:

  • Synthesis and characterization of a new PBR-targeted lanthanide chelate.
  • In vitro studies involving cellular uptake assays with PBR-overexpressing C6 glioblastoma cells.

Related Experiment Videos

  • Multimodal imaging experiments combining Magnetic Resonance Imaging (MRI) and fluorescence imaging.

    • Main Results:

    • Demonstrated cellular uptake of the novel imaging agent by PBR-overexpressing C6 glioblastoma cells.
    • Successful multimodal imaging of brain cancer cells using MRI and fluorescence.
    • Validation of the PBR-targeted agent's efficacy in vitro.

    Conclusions:

    • The novel PBR-targeted lanthanide chelate shows promise for molecular imaging of PBR-overexpressing cancers.
    • Multimodal imaging capabilities offer enhanced detection and characterization of brain tumors.
    • This approach could lead to earlier diagnosis and improved monitoring of diseases associated with PBR overexpression.